The Prevalence of Osmophobia in Migraine and Tension-Type Headache Patients and Its Association With Migraine Symptoms Over a Period of 6 Months
Osmophobia Is Likely the Best Phenotypic Indicator of Migraine: A Prospective, Non-Interventional, 6-Month Longitudinal Study
1 other identifier
observational
210
1 country
1
Brief Summary
The goal of this observational study is to learn about the frequency and diagnostic value of osmophobia, which is a sensitivity to smell, in people with migraine compared to those with tension-type headache. The main question it aims to answer is: Does osmophobia reliably indicate a migraine rather than a tension-type headache? Participants diagnosed with migraine or tension-type headache at the Headache Outpatient Department of Aeginition Hospital of Athens will record their headaches and any sensitivity to smells using a headache diary and a special osmophobia calendar over a period of six months. They will also complete questionnaires about migraine burden and related health conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2024
CompletedFirst Submitted
Initial submission to the registry
December 4, 2025
CompletedFirst Posted
Study publicly available on registry
January 9, 2026
CompletedJanuary 9, 2026
December 1, 2025
12 months
December 4, 2025
December 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The frequency of osmophobia in migraine and tension-type headache
Our aim is to estimate the prevalence of osmophobia in migraine and tension type headache in order to clarify its significance as a diagnostic tool for migraine
At baseline assessment over a six month period
Secondary Outcomes (1)
The correlation of osmophobia with headache type and symptoms and the calculation of its sensitivity and specificity
At baseline assessment over a six month period
Study Arms (2)
Patients with episodic or chronic migraine with or without aura
Patients with episodic or chronic tension type headache
Eligibility Criteria
Patients visiting the Headache Outpatient Department of Eginition Hospital of Athens
You may qualify if:
- Patients with a diagnosis of migraine or tension-type headache (ICHD-3)
- Age \>16 years
- Patients with or without medication overuse headache
- Patients with or without prophylaxis
- Patients with or without comorbidity with mood disorders
- Patients will have signed informed consent to participate in the study
You may not qualify if:
- Patients with primary or secondary anosmia
- Inability to obtain written consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aeginition Hospital of Athens
Athens, Greece
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Neurology Resident, Neurology Department of Hôpitaux Universitaires de Genève, PHD Student
Study Record Dates
First Submitted
December 4, 2025
First Posted
January 9, 2026
Study Start
January 8, 2024
Primary Completion
December 30, 2024
Study Completion
December 30, 2024
Last Updated
January 9, 2026
Record last verified: 2025-12